Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Patient communication AI company receives $65M in funding from private equity
Artera, a company that utilizes AI for patient communications, made the announcement while revealing it has achieved $100 million in annual revenue. Its products use AI for follow-ups after patient care, in addition to supporting clinical decisions.
Interventional cardiology groups unite to push the specialty forward
SCAI and CRT have announced a new partnership focused on education, advocacy and research.
3-in-1 TAVR guidewire linked to faster procedures, less radiation
The sensor-guided device delivers continuous hemodynamic measurements and rapid left ventricular pacing during TAVR procedures. Back in 2023, it was at the heart of a $253 million acquisition.
Stem cell company acquires 2 cardiology practices, calling them ‘the first of many’
Hemostemix believes its new cell therapy platform can help treat peripheral artery disease, congestive heart failure, cardiomyopathy and other serious medical conditions. The company plans on scooping up multiple practices to conduct additional research and increase the use of its platform.
FDA announces Class I recall of patches used for heart surgery
There is a risk of certain pericardial patches not being as strong or durable as needed. Customers are urged to identify, quarantine and replace these devices.

SCAI shares thorough guidance on out-of-hospital cardiac arrest

The Society of Cardiovascular Angiography and Interventions (SCAI) has shared a new guidance detailing the management of patients with out-of-hospital cardiac arrest (OHCA).

AI model reduces false-positive findings detected by implantable loop recorders

An AI algorithm could limit false-positive AFib episodes detected by implantable loop recorders (ILRs), according to new research presented during the 2020 Heart Rhythm Scientific Sessions.

FDA fast-tracks heart failure medication omecamtiv mecarbil

Omecamtiv mecarbil, a cardiac myosin activator being manufactured by Amgen and Cytokinetics to treat heart failure with reduced ejection fraction, has been granted a Fast Track designation by the FDA.

Sugary drink consumption boosts risk of CVD, stroke in women

Drinking just one sugary drink per day can increase a woman’s risk of cardiovascular disease (CVD) by 19%, according to new findings published in the Journal of the American Heart Association.

Health coverage during and after COVID: 6 fallouts to watch for

As analyzed by the Kaiser Family Foundation, the outlook for job-based insurance under some post-COVID scenarios is unsurprisingly bleak.

When patients can safely resume exercising after a COVID-19 diagnosis

As COVID-19 patients begin to bounce back, they are sure to have plenty of important questions about the recovery process.

COVID-19 especially harmful for heart transplant recipients

Heart transplant (HT) recipients have an increased risk of experiencing severe complications if infected with COVID-19, according to new findings published in JAMA Cardiology.

FDA clears Philips imaging solutions for management of cardiac, lung complications related to COVID-19

Royal Philips announced Wednesday, May 13, that its ultrasound imaging solutions have been cleared by the FDA for the management of cardiac and lung complications associated with COVID-19.

Clinical

Patient communication AI company receives $65M in funding from private equity

Interventional cardiology groups unite to push the specialty forward

3-in-1 TAVR guidewire linked to faster procedures, less radiation

Stem cell company acquires 2 cardiology practices, calling them ‘the first of many’

FDA announces Class I recall of patches used for heart surgery